Interferon alfa-2a (recombinant) April 12, 2017 Interferon alfa-2a (recombinant) Trade Name Roferon-A Orphan Indication AIDS related Kaposi's sarcoma USA Market Approval USA USA Designation Date 1987-12-14 00:00:00 Sponsor Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110